Allos Therapeutics, Inc. (NASDAQ:ALTH)
CAPS Rating:
A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No one has written a Pitch for ALTH yet. Tell us why you think ALTH will outperform or underperform the market.
RSS Headlines
Fool UK
